80 related articles for article (PubMed ID: 7365752)
1. Conformational energy differences between side chain alkylated analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Weintraub HJ; Nichols DE; Makriyannis A; Fesik SW
J Med Chem; 1980 Mar; 23(3):339-41. PubMed ID: 7365752
[TBL] [Abstract][Full Text] [Related]
2. Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.
Oberlender RA; Kothari PJ; Nichols DE; Zabik JE
J Med Chem; 1984 Jun; 27(6):788-92. PubMed ID: 6737421
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
4. Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)-and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
Jacob P; Shulgin AT
J Med Chem; 1983 May; 26(5):746-52. PubMed ID: 6842515
[TBL] [Abstract][Full Text] [Related]
5. Monomethylthio analogues of 1-(2,4,5-trimethoxyphenyl)-2-aminopropane.
Jacob P; Anderson G; Meshul CK; Shulgin AT; Castagnoli N
J Med Chem; 1977 Oct; 20(10):1235-9. PubMed ID: 903913
[TBL] [Abstract][Full Text] [Related]
6. Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.
Nichols DE; Woodard R; Hathaway BA; Lowy MT; Yom KW
J Med Chem; 1979 Apr; 22(4):458-60. PubMed ID: 430485
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) on schedule-controlled behavior.
Harris RA; Snell D; Loh HH
Pharmacol Biochem Behav; 1977 Oct; 7(4):307-10. PubMed ID: 928488
[TBL] [Abstract][Full Text] [Related]
8. In vitro O-demethylation of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Zweig JS; Castagnoli N
J Med Chem; 1977 Mar; 20(3):414-21. PubMed ID: 845874
[TBL] [Abstract][Full Text] [Related]
9. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
Glennon RA; Young R; Jacyno JM
Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
[TBL] [Abstract][Full Text] [Related]
10. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
Jacob JN; Nichols DE
J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
[TBL] [Abstract][Full Text] [Related]
11. Metabolic O-demethylation of the psychotomimetic amine 1-(2, 5-dimetroxy-4-methylphenyl)-2-aminopropane.
Zwieg JS; Castagnoli N
Psychopharmacol Commun; 1975; 1(4):359-71. PubMed ID: 1224005
[TBL] [Abstract][Full Text] [Related]
12. Electrochemical study of the hallucinogen (+-)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane.
Richter P; Morales A; Gómez-Jeria JS; Morales-Lagos D
Analyst; 1988 Jun; 113(6):859-63. PubMed ID: 3218759
[No Abstract] [Full Text] [Related]
13. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
[TBL] [Abstract][Full Text] [Related]
14. N-Hydroxylation of 1-(2,5-demethoxy-4-methylphenyl)-2-aminopropane by rabbit liver microsomes.
Gal J; Gruenke LD; Castagnoli N
J Med Chem; 1975 Jul; 18(7):683-8. PubMed ID: 1151987
[TBL] [Abstract][Full Text] [Related]
15. In vitro stereoselective metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. An apparent enantiomeric interaction.
McGraw NP; Callery SC; Castagnoli N
J Med Chem; 1977 Feb; 20(2):185-9. PubMed ID: 836489
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of R-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM), r-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) and 5-hydroxytryptamine on non-innervated vascular smooth muscle.
Dyer DC
Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):449-54. PubMed ID: 959651
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
Glennon RA; Young R; Rosecrans JA
Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
[TBL] [Abstract][Full Text] [Related]
18. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
Aulakh CS; Mazzola-Pomietto P; Wozniak KM; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1994 Jul; 270(1):127-32. PubMed ID: 8035308
[TBL] [Abstract][Full Text] [Related]
19. Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats.
Aulakh CS; Mazzola-Pomietto P; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1994 Oct; 271(1):143-8. PubMed ID: 7965707
[TBL] [Abstract][Full Text] [Related]
20. Chemical and biological studies of 1-(2,5-dihydroxy-4-methylphenyl)-2-aminopropane, an analogue of 6-hydroxydopamine.
Jacob P; Kline T; Castagnoli N
J Med Chem; 1979 Jun; 22(6):662-71. PubMed ID: 458821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]